Namodenoson, Matching placebo for namodenoson
CF102-212LD
Phase 2 small_molecule active
Quick answer
Namodenoson, Matching placebo for namodenoson for Non-Alcoholic Steatohepatitis (NASH) with F1-3 fibrosis is a Phase 2 program (small_molecule) at Can-Fite BioPharma with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Can-Fite BioPharma
- Indication
- Non-Alcoholic Steatohepatitis (NASH) with F1-3 fibrosis
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active